Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 304,633 clinical trials worldwide
Search
Showing 195401-195450 of 304,633 trials
Active filters:
Status: Completed
Clinical Trials (304,633)
NCT01600716
Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)
PHASE3
Completed
144 participants
Started: Jun 13, 2012 · Completed: Mar 27, 2015
3 conditions
1 sponsor
10 locations
NCT01791088
Sirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery
PHASE1
Completed
56 participants
Started: Jun 13, 2012 · Completed: Aug 17, 2018
2 conditions
2 sponsors
1 location
NCT01687335
Impact on the Nutritional State and the Quality of Life
N/A
Completed
102 participants
Started: Jun 12, 2012 · Completed: Mar 31, 2016
1 condition
1 sponsor
1 location
NCT01980355
TXA Study in Major Oncologic Surgery
NA
Completed
76 participants
Started: Jun 12, 2012 · Completed: Jul 29, 2020
3 conditions
1 sponsor
1 location
NCT01638000
A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment.
PHASE3
Completed
1,887 participants
Started: Jun 12, 2012 · Completed: Apr 24, 2013
3 conditions
1 sponsor
217 locations
NCT01606995
Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation
N/A
Completed
6,784 participants
Started: Jun 12, 2012 · Completed: Mar 31, 2015
1 condition
2 sponsors
21 locations
NCT01577511
Invasiveness and Chemoresistance of Cancer Stem Cells in Colon Cancer
N/A
Completed
60 participants
Started: Jun 12, 2012 · Completed: Oct 31, 2017
1 condition
1 sponsor
1 location
NCT04297228
Pediatric Obesity Treatment in a Safety Net Clinic: Piloting the Step by Step Program
NA
Completed
16 participants
Started: Jun 12, 2012 · Completed: Dec 17, 2012
2 conditions
2 sponsors
0 locations
NCT01618188
A Trial Investigating the Pharmacodynamic Properties of NN1218 in Subjects With Type 1 Diabetes
PHASE1
Completed
52 participants
Started: Jun 11, 2012 · Completed: Sep 7, 2012
2 conditions
1 sponsor
1 location
NCT01597622
BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115
PHASE3
Completed
142 participants
Started: Jun 11, 2012 · Completed: Sep 13, 2018
1 condition
2 sponsors
27 locations
NCT03225001
PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - Nested Registry 3/Valve-in-Valve
NA
Completed
197 participants
Started: Jun 11, 2012 · Completed: Oct 28, 2020
2 conditions
1 sponsor
47 locations
NCT01644955
Carboplatin in Treating Patients With Recurrent High-Grade Gliomas
PHASE1
Completed
10 participants
Started: Jun 11, 2012 · Completed: Dec 8, 2017
3 conditions
1 sponsor
1 location
NCT01482962
Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma
PHASE3
Completed
271 participants
Started: Jun 11, 2012 · Completed: Dec 18, 2017
2 conditions
1 sponsor
151 locations
NCT01578499
A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study)
PHASE3
Completed
131 participants
Started: Jun 11, 2012 · Completed: Jul 6, 2018
3 conditions
2 sponsors
41 locations
NCT01473940
Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery
PHASE1
Completed
21 participants
Started: Jun 11, 2012 · Completed: May 6, 2018
4 conditions
2 sponsors
1 location
NCT03565016
Consequences of At-risk Alcohol Consumption in ICU Patients
N/A
Completed
150 participants
Started: Jun 11, 2012 · Completed: Nov 25, 2013
2 conditions
1 sponsor
1 location
NCT01520220
Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms
PHASE1
Completed
100 participants
Started: Jun 11, 2012 · Completed: Feb 24, 2017
4 conditions
1 sponsor
9 locations
NCT01572922
Massive Iron Deposit Assessment
NA
Completed
142 participants
Started: Jun 11, 2012 · Completed: Feb 28, 2018
2 conditions
3 sponsors
1 location
NCT04843995
The Effect of Mid-urethral Sling on the Urethral Dynamic Shape and Motion
N/A
Completed
190 participants
Started: Jun 11, 2012 · Completed: May 14, 2021
1 condition
1 sponsor
1 location
NCT01512251
BKM120 Combined With Vemurafenib (PLX4032) in BRAFV600E/K Mutant Advanced Melanoma
PHASE1/PHASE2
Completed
8 participants
Started: Jun 9, 2012 · Completed: Mar 21, 2017
1 condition
2 sponsors
1 location
NCT05090956
Developpement of 3T MRI Protocol
NA
Completed
230 participants
Started: Jun 8, 2012 · Completed: Jan 29, 2020
3 conditions
1 sponsor
1 location
NCT01496313
To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer
PHASE4
Completed
81 participants
Started: Jun 8, 2012 · Completed: Jul 11, 2024
1 condition
1 sponsor
30 locations
NCT01621607
Individual Differences in Reward and Impulse Control
N/A
Completed
89 participants
Started: Jun 8, 2012 · Completed: Oct 3, 2017
2 conditions
1 sponsor
1 location
NCT01623596
Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis.
PHASE4
Completed
881 participants
Started: Jun 8, 2012 · Completed: Jul 13, 2015
1 condition
1 sponsor
123 locations
NCT01557166
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
PHASE3
Completed
359 participants
Started: Jun 7, 2012 · Completed: Jun 17, 2013
3 conditions
1 sponsor
42 locations
NCT01646216
Long Term Split Belt Treadmill Training for Stroke Recovery
NA
Completed
34 participants
Started: Jun 7, 2012 · Completed: Sep 30, 2017
2 conditions
5 sponsors
1 location
NCT01660776
BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology
N/A
Completed
105 participants
Started: Jun 7, 2012 · Completed: Oct 2, 2019
4 conditions
3 sponsors
4 locations
NCT01643824
Hypofractionated Proton Beam Radiotherapy for Hepatocellular Carcinoma
NA
Completed
112 participants
Started: Jun 7, 2012 · Completed: Apr 30, 2017
1 condition
1 sponsor
1 location
NCT03152539
Development of MRI Protocols and Associated Explorations (EEG, NIRS) in Healthy Volunteers
NA
Completed
733 participants
Started: Jun 7, 2012 · Completed: Jul 8, 2021
1 condition
1 sponsor
1 location
NCT01513759
Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy
PHASE3
Completed
150 participants
Started: Jun 7, 2012 · Completed: Feb 17, 2013
5 conditions
2 sponsors
22 locations
NCT01565707
A Study to Investigate How Effective and Safe Solifenacin Succinate Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug
PHASE3
Completed
189 participants
Started: Jun 7, 2012 · Completed: Jan 2, 2014
1 condition
1 sponsor
46 locations
NCT01386528
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
PHASE3
Completed
13 participants
Started: Jun 7, 2012 · Completed: Dec 1, 2013
2 conditions
1 sponsor
41 locations
NCT01756638
A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer
PHASE2
Completed
48 participants
Started: Jun 6, 2012 · Completed: Oct 17, 2014
1 condition
1 sponsor
19 locations
NCT01525550
A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors
PHASE4
Completed
106 participants
Started: Jun 6, 2012 · Completed: Jul 26, 2018
1 condition
1 sponsor
26 locations
NCT01846195
Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Patients During a Blood Draw
NA
Completed
50 participants
Started: Jun 6, 2012 · Completed: Mar 20, 2013
1 condition
2 sponsors
1 location
NCT01839240
Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia
PHASE1
Completed
50 participants
Started: Jun 6, 2012 · Completed: Aug 16, 2019
17 conditions
2 sponsors
1 location
NCT01629082
Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia
PHASE1
Completed
4 participants
Started: Jun 6, 2012 · Completed: Jun 27, 2018
5 conditions
2 sponsors
1 location
NCT01619085
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
PHASE3
Completed
752 participants
Started: Jun 6, 2012 · Completed: Feb 1, 2021
1 condition
1 sponsor
173 locations
NCT01566903
Neurovascular Non Contrast-Enhanced MR Angiography at 3T
N/A
Completed
80 participants
Started: Jun 5, 2012 · Completed: Nov 22, 2016
1 condition
1 sponsor
1 location
NCT01615068
An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)
N/A
Completed
1,007 participants
Started: Jun 5, 2012 · Completed: Nov 16, 2017
1 condition
1 sponsor
142 locations
NCT03219632
Fimasartan on Hypertensive Cardiac Disease With Left Ventricular Hypertrophy Estimated by ECG
N/A
Completed
72 participants
Started: Jun 5, 2012 · Completed: May 30, 2017
2 conditions
1 sponsor
0 locations
NCT01536405
Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)
PHASE3
Completed
1,412 participants
Started: Jun 5, 2012 · Completed: Jan 27, 2014
4 conditions
1 sponsor
0 locations
NCT01609790
Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors
PHASE2
Completed
137 participants
Started: Jun 4, 2012 · Completed: May 20, 2022
6 conditions
2 sponsors
244 locations
NCT01615796
Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Repeat IV Doses
PHASE1
Completed
86 participants
Started: Jun 4, 2012 · Completed: Feb 21, 2014
1 condition
1 sponsor
1 location
NCT01597908
Dabrafenib Plus Trametinib vs Vemurafenib Alone in Unresectable or Metastatic BRAF V600E/K Cutaneous Melanoma
PHASE3
Completed
704 participants
Started: Jun 4, 2012 · Completed: Apr 25, 2019
1 condition
1 sponsor
205 locations
NCT01611688
First Human Dose Trial of NNC0215-0384 in Subjects With Rheumatoid Arthritis
PHASE1
Completed
36 participants
Started: Jun 4, 2012 · Completed: Jun 17, 2013
2 conditions
1 sponsor
1 location
NCT01627288
Integrated Dose Escalation for Advanced, Localized Gynecologic Cancer (The IDEAL - GYN Trial)
NA
Completed
12 participants
Started: Jun 4, 2012 · Completed: Nov 16, 2019
2 conditions
1 sponsor
1 location
NCT01511913
A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma
N/A
Completed
1,411 participants
Started: Jun 3, 2012 · Completed: Dec 12, 2019
1 condition
1 sponsor
186 locations
NCT03166956
Effect of Glutamine and Vitamin C on Interleukin-6 and Clinical Outcomes in Surgical Intensive Care Unit Patients
NA
Completed
41 participants
Started: Jun 1, 2012 · Completed: Dec 31, 2014
1 condition
1 sponsor
0 locations
NCT02625506
Efficacy of Tramadol With Levobupivacaine for Modified Pectoral Nerve Block
NA
Completed
60 participants
Started: Jun 1, 2012 · Completed: Jan 1, 2016
2 conditions
1 sponsor
1 location
Previous
1
More pages
3906
3907
3908
3909
3910
3911
3912
More pages
6093
Next